Literature DB >> 28967176

Catalytic Asymmetric [8+2] Annulation Reactions Promoted by a Recyclable Immobilized Isothiourea.

Shoulei Wang1, Carles Rodríguez-Escrich1, Miquel A Pericàs1,2.   

Abstract

Higher-order cycloaddition reactions constitute an efficient approach towards the construction of medium to large ring systems. However, enantioselective versions of these transformations remain scarce, which hampers their deployment in medicinal chemistry, or any other discipline in which homochirality is deemed crucial. Herein, we report a novel method for the production of enantiomerically enriched cycloheptatrienes fused to a pyrrolidone ring on the basis of an isothiourea-catalyzed periselective [8+2] cycloaddition reaction between chiral ammonium enolates (generated in situ from carboxylic acids) and azaheptafulvenes. The resulting bicyclic compounds can be hydrogenated, but, most remarkably, they can also undergo completely regioselective [4+2] cycloaddition with active dienophiles to give architecturally complex polycyclic compounds in a straightforward manner.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  [8+2] cycloaddition; asymmetric catalysis; higher-order cycloaddition reactions; immobilized catalysts; isothioureas

Year:  2017        PMID: 28967176     DOI: 10.1002/anie.201707341

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  Rh2(ii)-catalyzed enantioselective intramolecular Büchner reaction and aromatic substitution of donor-donor carbenes.

Authors:  Dong Zhu; Tongxiang Cao; Kai Chen; Shifa Zhu
Journal:  Chem Sci       Date:  2022-01-19       Impact factor: 9.825

2.  Solvent directed chemically divergent synthesis of β-lactams and α-amino acid derivatives with chiral isothiourea.

Authors:  Dong-Sheng Ji; Hui Liang; Kai-Xuan Yang; Zhi-Tao Feng; Yong-Chun Luo; Guo-Qiang Xu; Yucheng Gu; Peng-Fei Xu
Journal:  Chem Sci       Date:  2022-01-18       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.